Model 3150 IPG
Inspire Medical Systems · Decision date Oct 22, 2026
What did the FDA decide?
The FDA recorded decision OK30 on 2026-10-22 for PMA supplement P130008/S147, submitted by Inspire Medical Systems as a 30-Day Notice under the process change category covering manufacturer, sterilizer, packager or supplier. The supplement concerns the Model 3150 Implantable Pulse Generator, a hypoglossal nerve stimulator for implanted apnea therapy (product code MNQ, listed under anesthesiology).
The recorded scope is expansion of the existing Model 3028 IPG final device manufacturer's site so that it can also produce the Model 3150 IPG. This is a manufacturing-site change within the existing approval, not a new approval of the device or its labeling. The source record includes no documents, so the site identity, inspection status and any conditions attached to OK30 remain unknown, as does whether the Model 3150 differs from the Model 3028 beyond production location.
FDA approval order statement
approval for the expansion of Inspire Medical's existing Model 3028 Implantable Pulse Generator (IPG) final device manufacturer's site to produce the Model 3150 IPG
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Anesthesiology
- Decision date
- Oct 22, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P130008/S147
- Regulatory pathway
- PMA supplement
- Applicant
- Inspire Medical Systems
- Product code
- MNQ
- Decision code
- OK30
- Decision date
- Oct 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, hypoglossal nerve, implanted, apnea.
- Applicant
- Inspire Medical Systems
- Product code
- MNQ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P130008. Subsequent supplements may change the device or its indications.
FDA decision timeline
P130008 · Original PMA
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S147 received
Application receipt date recorded by FDA.
P130008/S146 · Related supplement
Model 3150 IPG
P130008/S147 · FDA decision
30-Day Notice
P130008/S144 · Related supplement
INSPIRE II UPPER AIRWAY STIMULATOR
P130008/S148 · Related supplement
Model 4063 Dedicated Tray Sealer
Timeline entries are records held by MedtechLedger for P130008. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P130008
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Inspire Medical Systems | PMA approval | Apr 30, 2014 | FDA | |
Model 3150 IPGP130008/S146 | Inspire Medical Systems | PMA supplement | Oct 13, 2026 | FDA |
INSPIRE II UPPER AIRWAY STIMULATORP130008/S144 | Inspire Medical Systems | PMA supplement | Oct 26, 2026 | FDA |
Model 4063 Dedicated Tray SealerP130008/S148 | Inspire Medical Systems | PMA supplement | Nov 5, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Inspire Medical Systems
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 9700 63rd Ave. N., Suite 200, Maple Grove, MN, 55369
Sources and methodology
- Original FDA record: P130008/S147
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


